BioSpace News Archive

Additionally, the Company Continues to Realize Material Progress with Respect to its Two Ongoing Biotechnology Initiatives NEW YORK, NY, July 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnol

Align Technology, Inc. (Nasdaq: ALGN) today reported financial results for the second quarter of 2020 (“Q2’20”). Q2’20 total revenues were $352.3 million, down 41.3% year-over-year. Q2’20 Clear Aligner revenues were $298.3 million, down 39.9% year-over-year and Q2’20 Imaging Systems and CAD/CAM Services (formerly Scanner and Services) revenues were $54.0 million,

Invacare Corporation announces that it will release its financial results for the second quarter ended June 30, 2020, after the market closes on Wednesday, August 5, 2020. The company will provide a live conference call and webcast to discuss these financial results on Thursday, August 6, 2020 at 8:30 AM ET.

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter financial results on Wednesday, August 5, 2020, after the close of the U.S. financial markets.

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) announced today that effective June 16, 2020, the Company has granted nonstatutory stock options for the purchase of up to 30,000 shares of the Company’s common stock to one new employee as inducement awards under the Company’s Inducement Award Plan.

ICON plc, a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, announced that all resolutions at the Annual General Meeting of the Company held on July 21, 2020 were all duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders dated June 9, 2020 and are available on the ICON plc website.

Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced that it will release second quarter 2020 financial results on August 4, 2020.

SmileDirectClub, Inc., the first direct-to-consumer telehealth platform for teeth straightening, announced it will report results for the second quarter 2020 on Wednesday, August 12 after close of market.

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 first quarter financial results at 10:00 a.m. Eastern Time on Tuesday, August 4, 2020.

Sanofi Pasteur, the vaccines global business unit of Sanofi, today shipped the first of its influenza vaccine doses to health care providers in the U.S. to help protect Americans of all ages for the upcoming 2020-2021 flu season